BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Week in Review: Tasly Pharmaceutical to Build US Manufacturing Facility


6/6/2011 12:24:08 PM

June 4, 2011 -- Tianjin Tasly Pharma will invest $40 million into a US facility to support its TCM-based treatment for coronary disease; Livzon Pharma will spend $154 million to build two new API fabrication facilities; Pfizer and Zhejiang Hisun Pharma signed an MOU to form a branded generics JV; Zhejiang Huahai Pharma received FDA approval of a generic Alzheimer’s treatment, donepezil; KingMed Diagnostics, a China diagnostic laboratory, will get second-opinion pathology consultations from the University of Pennsylvania Medical Center; First China Pharma has begun due diligence on its acquisition of a South China drug distributor; D-Pharm out-licensed China rights for its epilepsy treatment to Jiangsu Nhwa Pharma; and all eleven defendants charged with selling counterfeit Avastin have pled guilty. More details….

Stock Symbols: (SHA: 600535) (SHE: 200513) (NYSE: PFE) (SHA: 600267) (SHE: 600521) (OTCBB: FCPG) (TASE: DPRM) (SHE: 2262)



Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES